LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Medicines For Rare Diseases And Children
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕
  • 27/10/2023

    EFIB Rotterdam Statement 2023
  • 24/10/2023

    Innovative biotech industry can support Europe’s health resilience and autonomy
  • 09/10/2023

    The Future of Health is Biotech: EuropaBio’s Position on the Revision of the EU Pharmaceutical Legislation
  • 14/09/2023

    Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products
  • 14/09/2023

    European Commission proposal on New Genomic Techniques – a first step towards modernizing the EU GMO framework
  • 28/07/2023

    EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management
  • 17/07/2023

    EuropaBio position paper for the proposal on establishing a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem (Net-Zero Industry Act)
  • 13/07/2023

    Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs
  • 05/07/2023

    The NGT proposal is an important step towards Europe’s bioeconomy-driven strategic autonomy, competitiveness and sustainability ambitions
  • 23/05/2023

    EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation
  • 10/05/2023

    Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski
  • 04/05/2023

    EuropaBio response to the public consultation on EU Taxonomy Environmental Delegated Act
  • 23/02/2023

    EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation
  • 17/02/2023

    Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics
  • 01/02/2023

    Joint Statement: The Data Act is a leap into the unknown
  • 28/11/2022

    Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework
  • 16/11/2022

    Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides
  • 09/09/2022

    The Essential Role of Enzymes | The unintended impact of the REACH revision on Enzymes – and consequences for EU Green Deal Objectives
  • 08/09/2022

    The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance
  • 07/09/2022

    EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)
1234
Next page
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member